Sensorin continues its development of a self-calibrating pH sensor, which it hopes to market later this year. At Interphex 2010, CEO Carolyn Kahn explains why she feels the sensor is a breakthrough in biopharma process monitoring, and talks about single-use technologies and future developments.
